← Leaderboards
Shikhar Mehrotra
Medical University Of South Carolina
$11,720,155
Attributed
$13,382,971
Total exposure
13
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,382,971 · 13
By mechanism
R01$10,781,178 · 7
P01$1,523,761 · 3
R21$1,078,032 · 3
Top collaborators
- Viswanathan Palanisamy6 shared
- Brian Hess2 shared
Most similar at Medical University Of South Carolina
Same institution · by research overlap
- Radhika Gudi$1,050,139
- Chenthamarakshan Vasu$10,772,753
- Chrystal Mary Paulos$6,163,426
- Christopher Bryce Johnson$156,256
- John J Lemasters$27,282,033
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseCellsTumorT-LymphocyteIn VivoMalignant NeoplasmsMediatingT Cell ResponseTumor GrowthImmunotherapyExhibitsLeadTumor MicroenvironmentPhenotypeImmuneMetabolismProgramsAntigensGenerationsT Cell TherapyCytokineEquilibriumPropertyMetabolic
Grant awards (39)
Dissecting the Mechanism for Transient ER Stress-Induced Anti-Tumor T Cell Response$626,534
R01 · FY2025 · CA · contact PI
Targeting S1P-ACC Axis to Overcome MDSC Suppression$563,233
R01 · FY2025 · CA · contact PI
Assessing Metabolically Reprogrammed and Purified CD19-CAR-T in NHL and CLL$532,785
R01 · FY2025 · CA
Assessing Metabolically Reprogrammed and Purified CD19-CAR-T in NHL and CLL$533,348
R01 · FY2024 · CA
Anti-oxidant and Metabolic Phenotype in Regulating Tumor Specific T cell Memory Response$485,903
R01 · FY2024 · CA · contact PI
Intersections of RNA-binding proteins and T-cells in oral epithelial plasticity$441,308
R01 · FY2024 · DE
Understanding Metabolic and Epigenetic Crossâ talk in Potent Antiâ tumor T cells$440,560
R01 · FY2024 · CA · contact PI
Anti-oxidant and Metabolic Phenotype in Regulating Tumor Specific T cell Memory Response$501,247
R01 · FY2023 · CA · contact PI
Understanding Metabolic and Epigenetic Crossâ talk in Potent Antiâ tumor T cells$454,472
R01 · FY2023 · CA · contact PI
Intersections of RNA-binding proteins and T-cells in oral epithelial plasticity$451,130
R01 · FY2023 · DE
Intersections of RNA-binding proteins and T-cells in oral epithelial plasticity$5,314
R01 · FY2023 · DE
Anti-oxidant and Metabolic Phenotype in Regulating Tumor Specific T cell Memory Response$501,247
R01 · FY2022 · CA · contact PI
Understanding Metabolic and Epigenetic Crossâ talk in Potent Antiâ tumor T cells$454,467
R01 · FY2022 · CA · contact PI
Intersections of RNA-binding proteins and T-cells in oral epithelial plasticity$451,881
R01 · FY2022 · DE
Anti-oxidant and Metabolic Phenotype in Regulating Tumor Specific T cell Memory Response$511,094
R01 · FY2021 · CA · contact PI
Understanding Metabolic and Epigenetic Crossâ talk in Potent Antiâ tumor T cells$463,746
R01 · FY2021 · CA · contact PI
Intersections of RNA-binding proteins and T-cells in oral epithelial plasticity$454,933
R01 · FY2021 · DE
Core B: Animal Models and Pathology$207,469
P01 · FY2021 · CA · contact PI
Anti-oxidant and Metabolic Phenotype in Regulating Tumor Specific T cell Memory Response$522,428
R01 · FY2020 · CA · contact PI
Understanding Metabolic and Epigenetic Crossâ talk in Potent Antiâ tumor T cells$463,746
R01 · FY2020 · CA · contact PI
Intersections of RNA-binding proteins and T-cells in oral epithelial plasticity$454,933
R01 · FY2020 · DE
Core B: Animal Models and Pathology$204,547
P01 · FY2020 · CA · contact PI
Core B: Animal Models and Pathology$1
P01 · FY2019 · CA · contact PI
Core B: Animal Models and Pathology$214,174
P01 · FY2018 · CA · contact PI
Core B: Animal Models and Pathology$97,820
P01 · FY2017 · CA · contact PI
Core B: Animal Models and Pathology$220,491
P01 · FY2016 · CA · contact PI
Mechanisms of SK2/S1P Signaling in Regulating Tumor Immunotherapy$162,581
R21 · FY2016 · CA · contact PI
Mechanisms of SK2/S1P Signaling in Regulating Tumor Immunotherapy$195,098
R21 · FY2015 · CA · contact PI
Oxidative stress and AICD in memory T cell persistence$287,975
R01 · FY2014 · CA · contact PI
Oxidative stress and AICD in memory T cell persistence$279,069
R01 · FY2013 · CA · contact PI
Oxidative stress and AICD in memory T cell persistence$296,881
R01 · FY2012 · CA · contact PI
Mouse Core$294,997
P01 · FY2012 · CA · contact PI
Impact of AICD on TCR Transduced T Cells for Adoptive Immunotherapy$284,262
P01 · FY2012 · CA · contact PI
Oxidative stress and AICD in memory T cell persistence$296,881
R01 · FY2011 · CA · contact PI
Oxidative stress and AICD in memory T cell persistence$306,063
R01 · FY2010 · CA · contact PI
Isolation and Characterization of Prostrate Antigen Specific High Affinity TCR$194,700
R21 · FY2010 · CA · contact PI
Development & Characterization of Tyrosinase Epitope Specific TCR Transgenic Mice$164,278
R21 · FY2010 · AR · contact PI
Development & Characterization of Tyrosinase Epitope Specific TCR Transgenic Mice$199,125
R21 · FY2009 · AR · contact PI
Isolation and Characterization of Prostrate Antigen Specific High Affinity TCR$162,250
R21 · FY2009 · CA · contact PI